Metabomed
PrivateLast Round
Series B
Dec 19, 2019
Total Funding Raised
$35.5M
Company Overview
Metabomed is a biotechnology company that develops small molecule drugs directed against novel targets in the field of cancer metabolism.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metabomed Comparables
Compare Metabomed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReEngage Therapeutics | 80% | |
| Lime Therapeutics | 73% | |
| KSQ Therapeutics | 71% | |
Metabomed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 19, 2019 | ||||
| Series A | Apr 4, 2016 | ||||
| Seed | Nov 28, 2013 |
Metabomed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| M Ventures | Series A, Series B, Seed |
| Pontifax Venture Capital | Series A, Seed |
| Boehringer Ingelheim Venture Fund | Series A, Seed, Series B |
| Pfizer | Series A |
| Arkin Bio Ventures | Series B |
| Pfizer Ventures | Series B |
| Technion Research & Development Foundation | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 19, 2019
$13M round with participation from Pfizer Ventures and M Ventures.
- Apr 4, 2016
$18M round with participation from Pfizer and Boehringer Ingelheim.
Metabomed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Metabomed's valuation, stock price, and market status.